ImmunoPrecise’s proprietary technologies and products are positioned on the leading edge of antibody development, innovating our industry as a single source provider of the full complement of antibody discovery platforms. As an investor in ImmunoPrecise Antibodies, you’re joining us at the forefront of new, exciting, and valuable advancements in next-generation antibody discovery.
Investor RelationsFor investor inquiries please contact: LifeSci Advisors
Financial StatementsPlease find our financials on Sedar in English and Français.
Analyst CoverageDownload December 14, 2021 Report
Download November 26, 2021 Report
Download October 25, 2021 Report
+1 (212) 312-6764
ImmunoPrecise NewsletterCheck out our most recent blog post:SARS-CoV-2 Infection Process
Earnings CallThe Company held an earnings conference call via webcast on Decemeber 13th, 2021. View a recording of the earnings call.
Sign Up for
Enter your email to receive financial information by email.